Stuart Poulton, EVP, Chief Development Officer: Karyopharm Therapeutics KPTI Sell · Filed 23/02/17

Trade details

Type: Insider sale
Amount: $18,071.35
Shares · price: 5,665 sh · $3.19 a share
Held after: 64,335 sh
Stock: Karyopharm Therapeutics KPTI
Person: Stuart PoultonEVP, Chief Development Officer
Trade date: 23/02/15
Filed: 23/02/17
Days to filing: 2 days

Sold 8.1% of holdings

Share of holding sold: 8.1%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/16~23/03/17

Stuart Poulton's recent trades

Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,829
403 sh
$3,829
Filed 05/15
Traded 05/14
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$48K
5,101 sh
$48K
Filed 03/03
Traded 03/02
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,262
378 sh
$3,262
Filed 02/19
Traded 02/17
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,578
401 sh
$2,578
Filed 25/09/16
Traded 25/09/15
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$835
191 sh
$835
Filed 25/07/30
Traded 25/07/29

Stuart Poulton, Chief Officer — sold $18.1K of Karyopharm Therapeutics KPTI · 8.1% of holdings | Whalegun